ホシノ ジユンイチ
Hoshino Jiyun'ichi
星野 純一 所属 医学部 医学科(東京女子医科大学病院) 職種 教授・基幹分野長 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | テリパラチド治療後の低ホスファターゼ血症関連骨粗鬆症の骨組織形態学的解析(A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment) |
掲載誌名 | 正式名:Internal medicine 略 称:Intern Med ISSNコード:09182918/13497235 |
掲載区分 | 国外 |
出版社 | (一社)日本内科学会 |
巻・号・頁 | 62(1),pp.75-79 |
著者・共著者 | Mizuno Hiroki, Sawa Naoki, Sekine Akinari, Inoue Noriko, Oba Yuki, Ikuma Daisuke, Yamanouchi Masayuki, Hasegawa Eiko, Suwabe Tatsuya, Suzuki Hisanori, Hoshino Junichi, Ubara Yoshifumi |
発行年月 | 2023/01/01 |
概要 | A 79-year-old man was admitted with a compression fracture of the first lumbar vertebra. His alkaline phosphatase (ALP) level was 35 IU/L, and his dual energy X-ray absorptiometry T score was -3.7 standard deviations, indicating osteoporosis. A genetic analysis showed a mutation of the alkaline phosphatase biomineralization-associated gene encoding tissue-nonspecific alkaline phosphatase. Hypophosphatasia-related osteoporosis was diagnosed. Alendronate, teriparatide, and minodronate were administered in that order. The ALP level increased during teriparatide use. A bone biopsy performed after three years of teriparatide treatment showed that cancellous bone was adynamic. In cortical bone, tetracycline double-labeling indicates enhanced bone formation. Teriparatide may thus be a viable treatment option even in patients with hypophosphatasia. |
DOI | 10.2169/internalmedicine.9624-22 |
文献番号 | 2024036556 |
PMID | 35650135 |